Novorapid subcutenous inj.

Country: Namibia

Language: English

Source: Namibia Medicines Regulatory Council

Active ingredient:

Insulin Aspart

Available from:

NOVO NORDISK (PTY) LIMITED

Dosage:

Each 1ml aqueous, neutral, and sterile solution contains Insulin Aspart 100 IU

Pharmaceutical form:

Injection

Authorization status:

NS1/NS2

Authorization date:

1970-01-01

Search alerts related to this product